ArticleNeoplasia (New York, N.Y.)
Exceptionally potent anti-tumor bystander activity of an scFv:sTRAIL fusion protein with specificity for EGP2 toward target antigen-negative tumor cells.
Edwin Bremer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
cites it